Abstract:Glutathione levels in neurons and glial cells were investigated in a neuronal-glial coculture and in separate cultures. Brain cell suspensions obtained from cerebral hemispheres of fetal rats were cultured, and after 5 days the glutathione content of this cell population, consisting mainly of neurons and astroglial cells, was 23.0 nmol/mg of cell protein, with a significantly high content in glial cells (28.0 nmol/mg of protein) in comparison with neurons (18.8 nmol/mg of protein). When the neurons and glial c… Show more
“…Both NAC and glutathione ethyl ester provided significant protection against cell death whereas cystine and methionine were without effect. The lack of effect of cystine is consistent with previous reports that neurons can take up cysteine, but not cystine (Sagara et al, 1993). As expected, methionine afforded no protection.…”
Section: Neuroblastoma Cellssupporting
confidence: 92%
“…Glutathione ethyl ester is an esterified form of glutathione that is able to cross the cell membrane against the concentration gradient (Anderson et al, 2004). Cystine is the disulfide (oxidized) form of cysteine that is readily taken up by astrocytes, but not neurons (Sagara et al, 1993). Since astrocytes are unable to synthesize GSH from methionine, the addition of methionine to the media served as a negative control.…”
“…Both NAC and glutathione ethyl ester provided significant protection against cell death whereas cystine and methionine were without effect. The lack of effect of cystine is consistent with previous reports that neurons can take up cysteine, but not cystine (Sagara et al, 1993). As expected, methionine afforded no protection.…”
Section: Neuroblastoma Cellssupporting
confidence: 92%
“…Glutathione ethyl ester is an esterified form of glutathione that is able to cross the cell membrane against the concentration gradient (Anderson et al, 2004). Cystine is the disulfide (oxidized) form of cysteine that is readily taken up by astrocytes, but not neurons (Sagara et al, 1993). Since astrocytes are unable to synthesize GSH from methionine, the addition of methionine to the media served as a negative control.…”
“…Alternatively, the efflux have different cellular origin. Glutathione is present in both neurons and glia (29,30,(82)(83)(84)(85)(86), but as no functional NMDA receptors appear to be located on hippocampal glia cells (87), the most straightforward explanation for the increase in glutathione efflux is neuronal release. However, it cannot be excluded that NMDA-receptor stimulation induces a release of a substance from neurons that evokes glutathione release from the glial cells.…”
Section: Discussionmentioning
confidence: 99%
“…Glutathione may also increase NMDA receptor responses by interacting with its redox sites (26)(27)(28). Furthermore, because the breakdown products of glutathione include cysteine, glycine, and cysteineglycine, extracellular breakdown may supply surrounding cells with these glutathione precursors (29)(30)(31). Despite the key function of glutathione in intracellular redox regulation and the putative extracellular effects in brain, the mechanisms and factors determining the efflux remain unknown.…”
N-Methyl-D-aspartate (NMDA)-receptor stimulation evoked a selective and partly delayed elevated efflux of glutathione, phosphoethanolamine, and taurine from organotypic rat hippocampus slice cultures. The protein kinase inhibitors H9 and staurosporine had no effect on the efflux. The phospholipase A 2 inhibitors quinacrine and 4-bromophenacyl bromide, as well as arachidonic acid, a product of phospholipase A 2 activity, did not affect the stimulated efflux. Polymyxin B, an antimicrobal agent that inhibits protein kinase C, and quinacrine in high concentration (500 μM), blocked efflux completely. The stimulated efflux after but not during NMDA incubation was attenuated by a calmodulin antagonist (W7) and an anion transport inhibitor (DNDS). Omission of calcium increased the spontaneous efflux with no or small additional effects by NMDA. In conclusion, NMDA receptor stimulation cause an increased selective efflux of glutathione, phosphoethanolamine and taurine in organotypic cultures of rat hippocampus. The efflux may partly be regulated by calmodulin and DNDS sensitive channels.
“…The dipeptide CysGly is hydrolyzed by neuronal dipeptidase into cysteine and glycine (42,60). Neurons utilize cysteine but not cystine for GSH synthesis, whereas glial cells utilize both (43,54). The CSF cysteine concentration was much higher than that of cystine (56).…”
Abstract. The brain is among the major organs generating large amounts of reactive oxygen species and is especially susceptible to oxidative stress. Glutathione (GSH) plays critical roles as an antioxidant, enzyme cofactor, cysteine storage form, the major redox buffer, and a neuromodulator in the central nervous system. GSH deficiency has been implicated in neurodegenerative diseases. GSH is a tripeptide comprised of glutamate, cysteine, and glycine. Cysteine is the rate-limiting substrate for GSH synthesis within neurons. Most neuronal cysteine uptake is mediated by sodium-dependent excitatory amino acid transporter (EAAT) systems, known as excitatory amino acid carrier 1 (EAAC1). Previous studies demonstrated EAAT is vulnerable to oxidative stress, leading to impaired function. A recent study found EAAC1-deficient mice to have decreased brain GSH levels and increased susceptibility to oxidative stress. The function of EAAC1 is also regulated by glutamate transporter associated protein 3-18. This review focuses on the mechanisms underlying GSH synthesis, especially those related to neuronal cysteine transport via EAAC1, as well as on the importance of GSH functions against oxidative stress.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.